CTRI/2015/02/005511Not yet recruitingPhase 3
Retinal image acquisition with Brien Holden Visionâ?¢ retinal camera in normal eyes and eyes with diabetic retinopathy and glaucoma - IRC
Australian Government Cooperative Research Centres Program0 sites2,800 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 3
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 2,800
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
Inclusion Criteria
- •Group I: Healthy participants enrolled in the study must:
- •be male or female aged forty years or over
- •give informed consent;
- •be willing to comply with the clinical study visit schedule as directed by the investigator;
- •have no anterior or posterior segment condition other than refractive error, cataract, pseudophakia or posterior capsular opacification;
- •have vision correctable to at least 6 by12 or better in each eye with spectacles.
- •no visual field defects suggestive of glaucoma on perimetry;
- •Group II: Participants with diabetic retinopathy (DR) enrolled must:
- •be male or female aged 40 years or over
- •give informed consent ;
- •be diagnosed to be Diabetic;
- •be willing to comply with the clinical study visit schedule as directed by the investigator;
- •have eyes classifiable as having no retinopathy, minimal non-proliferative DR, mild- moderate non proliferative DR, severe non-proliferative DR and proliferative DR;
- •have sufficient media clarity for obtaining retinal images.
- •Group III: Participants with glaucoma enrolled must:
- •be male or female aged 40 years or over
- •give informed consent
- •have glaucomatous visual field defects
- •have sufficient media clarity for obtaining retinal images
Exclusion Criteria
- •History of chronic renal failure requiring dialysis or kidney transplant;
- •any active ocular inflammation or infection or evidence of toxoplasmosis or cytomegalovirus or herpes infection of eye;
- •eyes with dilated pupil diameter less than 3mms;
- •In addition, participants with diabetic retinopathy must NOT have
- •Any ocular disease other than DR that may confound diagnosis (exudative AMD, retinal vein occlusion, uveitis, angioid streaks, central serous chorioretinopathy, histoplasmosis, macular hole, retinal detachment, pathological myopia, epiretinal membrane);
- •In addition, participants with glaucoma must NOT have
- •Eyes with field loss attributed to non-glaucoma conditions
Investigators
Similar Trials
Recruiting
Not Applicable
Diabetic Eye SentinelPatients who have diabetes mellitusDiabetes MellitusDiabetic RetinopathyTCTR20210618004ational Research Council of Thailand (NRCT)250
Not yet recruiting
Not Applicable
Automated Analysis of Retinal Images for Detection of Diabetic Retinopathy using Artificial Intelligence (AI)Patients with any type of diabetes mellitusDiabetic retinopathy screeningImage enhancementImage analysisColor retinal imageArtificial intelligenceDiabetic retinopathyTCTR20211122006ational Higher Education Science Research and Innovation Policy Council (NXPO)10,000
Not yet recruiting
Not Applicable
Fundus Image Grading and Disease DetectioCTRI/2020/07/026415Gibbr Technologies Pvt Ltd
Not yet recruiting
Not Applicable
Multimodal Optical-imaging of Retinal manifestations of Alzheimer*s Diseasedementia10029301Alzheimer's DiseaseNL-OMON52275Vrije Universiteit Medisch Centrum150
Completed
Not Applicable
Retinal imaging (Spectral-domain Optical coherence tomography; SD-OCT) in Parkinson diseaseParkinson diseaseJPRN-UMIN000017596Saitama Medical University Hospital100
